This will be a single-arm open-label prospective pilot feasibility trial recruiting 10 adult
patients with recurrent glioblastoma who are assigned to receive the personalized study
treatment based on the genetic profile of their recurrent GBM tumor resected at the time of
surgery. It will be aimed to gather preliminary information on the study intervention and the
feasibility of conducting a full-scale trial.